prevention of post-ERCP pancreatitis by placement of 4Fr prophylactic pancreatic duct stent

JRCT ID: jRCTs052180132

Registered date:18/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: biliary duct disease
• Date of first enrollment: 17/12/2018
• Target sample size: 250
• Study type: Interventional
• Intervention(s): 4Fr placement of prophylactic pancreatic duct stent

Outcome(s)

• Primary Outcome: Frequency of post-endoscopic retrograde cholangiopancreatography pancreatitis

Secondary Outcome

Success rate of placing prophylactic pancreatic duct stent.
Frequency of more than moderate post-endoscopic retrograde cholangiopancreatography pancreatitis.
Frequency of complication other than post-endoscopic retrograde cholangiopancreatography pancreatitis.

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1)native papilla
2)patient who is performed endoscopic retrograde cholangiography purposes only in the biliary duct

Exclude criteria

1)acute pancreatitis
2)postoperative reconstructed intestinal tract (Billroth ii, Roux-en-Y method)
3)patient with serious systemic illness, dangerous condition of life
4)intraductal papillary mucinous neoplasm
5)complete obstruction of main pancreatic duct
6)patient who already registered in this study once

Related Information

• Primary Sponsor: Kitano Masayuki
• Secondary ID(s): UMIN000031972